https://www.marketscreener.com/quote/stock/SHANGHAI-JUNSHI-BIOSCIENC-55886669/news/Junshi-Biosciences-Announces-Approval-of-the-sNDA-for-Toripalimab-for-the-1st-Line-Treatment-of-Rena-46382856/?utm_source=telegram&utm_medium=social&utm_campaign=share